Company: NGVT
Filing Date: 2025-02-25
Form Type: DEFA14A
Source: 0001140361-25-005894
Chunk: 8

Company: Ingevity Corp
Filing Date: 2025-02-25
Form: DEFA14A
Chunk 8
---
 and talented employees provide a strong foundation for profitable growth. With this in mind, I want to emphasize that it is business as usual. Today’s news has no impact on our strategic objectives or daily operations and should not distract you from your day-to-day responsibilities. As our recently announced full-year 2024 results show, our performance improvement initiatives are driving positive momentum across our businesses. Since stepping into the role of interim CEO, I have seen firsthand the dedication of this team, and I know that with focus, we can execute. As always, please continue to work safely. Thank you for your commitment to Ingevity, our customers and each other. Best Regards, Luis Fernandez-Moreno Consistent with usual policies, please direct inquiries about this news from media or anyone outside of our company to Caroline Monahan at 843-740-2068 or media@ingevity.com. Stockholder inquiries should be directed to John E. Nypaver, Jr. at 843-740-2002 or investors@ingevity.com. Important Additional Information Regarding Proxy Solicitation:Ingevity intends to file a proxy statement and WHITE proxy card with the SEC in connection with the solicitation of proxies for Ingevity’s 2025 annual meeting of stockholders (the “Proxy Statement” and such meeting the “2025 Annual Meeting”). Ingevity, its directors and certain of its executive officers may be deemed to be participants in the solicitation of proxies from stockholders in respect of the 2025 Annual Meeting. Additional information regarding the identity of these potential participants and their respective interests in Ingevity by security holdings or otherwise will be set forth in the Proxy Statement and other materials to be filed with the SEC in connection with the 2025 Annual Meeting. Information relating to the foregoing can also be found in Ingevity’s definitive proxy statement for its 2024 annual meeting of stockholders, filed with the SEC on March 11, 2024(the “2024 Proxy Statement”). Please refer to the sections captioned “Ownership of Equity Securities,” “Director Compensation,” “Compensation Discussion and Analysis” and “Compensation Tables and Other Matters” in the 2024 Proxy Statement. To the extent the holdings of such participants in Ingevity’s securities have changed since the amounts described in the 2024 Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC, including: